Education
About Us
Working with TipRanks
Follow Us
Cyfuse Biomedical K.K. (JP:4892)
:4892
4892 Stock Chart & Stats
¥560.00
¥1.00(0.23%)
At close: 4:00 PM EST
¥560.00
¥1.00(0.23%)
Day’s Range― - ―
52-Week Range¥433.00 - ¥1,412.00
Previous CloseN/A
Volume38.50K
Average Volume (3M)50.89K
Market Cap
¥5.37B
Enterprise Value¥2.94B
Total Cash (Recent Filing)¥2.70B
Total Debt (Recent Filing)¥766.00M
Price to Earnings (P/E)―
Beta0.57
Next Earnings
Feb 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-25.83
Shares Outstanding9,581,800
10 Day Avg. Volume43,580
30 Day Avg. Volume50,893
Financial Highlights & Ratios
PEG Ratio-0.10
Price to Book (P/B)1.43
Price to Sales (P/S)66.83
P/FCF Ratio-4.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
4892 FAQ
What was Cyfuse Biomedical K.K.’s price range in the past 12 months?
Cyfuse Biomedical K.K. lowest stock price was ¥433.00 and its highest was ¥1412.00 in the past 12 months.
What is Cyfuse Biomedical K.K.’s market cap?
Cyfuse Biomedical K.K.’s market cap is ¥5.37B.
When is Cyfuse Biomedical K.K.’s upcoming earnings report date?
Cyfuse Biomedical K.K.’s upcoming earnings report date is Feb 12, 2026 which is in 53 days.
How were Cyfuse Biomedical K.K.’s earnings last quarter?
Cyfuse Biomedical K.K. released its earnings results on Nov 14, 2025. The company reported -¥25.83 earnings per share for the quarter, missing the consensus estimate of N/A by -¥25.83.
Is Cyfuse Biomedical K.K. overvalued?
According to Wall Street analysts Cyfuse Biomedical K.K.’s price is currently Overvalued.
Does Cyfuse Biomedical K.K. pay dividends?
Cyfuse Biomedical K.K. does not currently pay dividends.
What is Cyfuse Biomedical K.K.’s EPS estimate?
Cyfuse Biomedical K.K.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cyfuse Biomedical K.K. have?
Cyfuse Biomedical K.K. has 9,581,800 shares outstanding.
What happened to Cyfuse Biomedical K.K.’s price movement after its last earnings report?
Cyfuse Biomedical K.K. reported an EPS of -¥25.83 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.853%.
Which hedge fund is a major shareholder of Cyfuse Biomedical K.K.?
Currently, no hedge funds are holding shares in JP:4892
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cyfuse Biomedical K.K.
Cyfuse Biomedical K.K. engages in the development, manufacture, and sale of regenerative medicine products in Japan. It develops cellular products in the field of regenerative therapy; and undertakes contract for cellular products for research and development. The company also offers Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bones, blood vessels, and nerves; regenova, a bio 3D printer for 3D stacking of cells; and S-PIKE that develops 3D-structures from cells. Cyfuse Biomedical K.K. was incorporated in 2010 and is based in Tokyo, Japan.
Technical Analysis
Solasia Pharma KK
―
Morishita Jintan Co., Ltd.
―
Symbio Pharmaceuticals Limited
―
Medrx Co., Ltd.
―
Modalis Therapeutics Corporation
―